Fox Chase Cancer Center doctors are not just clinical specialists—they’re also world-renowned cancer researchers. The results of studies conducted by Fox Chase doctors have been crucial in advancing our understanding of neuroendocrine tumor diagnosis and treatment around the world.
In addition to the latest treatments for neuroendocrine tumors, Fox Chase is actively developing and evaluating a number of new therapies, often before they are available anywhere else. We encourage eligible patients to participate in clinical trials that are available and appropriate for their stage and type of neuroendocrine tumors.
Featured trial:
- Cabozantinib for neuroendocrine tumors IRB 19-2004